MCRA is now part of IQVIA MedTech. MedTech innovators have access to specialized expertise across 15+ therapeutic areas, backed by proven experience in medical devices, IVD, biologics, and digital health. Together, our regulatory, clinical, and commercialization teams help connect strategy, evidence, and execution across the MedTech product lifecycle. Follow IQVIA MedTech on LinkedIn for news and updates. To learn more, visit iqviamedtech.com.
External link for MCRA, an IQVIA business
MCRA, an IQVIA business reposted this
IVD development requires a different playbook. As evidence expectations continue to rise, innovators need strategies that anticipate regulatory requirements and reduce risk. Hear our Vice President, Kelley Kennedy, and Vice President of IVD Regulatory Affairs, James Mullally, discuss how an experienced team can help build confidence at every stage of development. https://bit.ly/4f4xdHd
MCRA, an IQVIA business reposted this
Is your UDI strategy ready for the next phase of EUDAMED? A strong approach can help improve device traceability, strengthen data governance and support regulatory readiness. Explore key considerations in our blog by Hamidreza Alidousti, MEng, Ph.D., Michelle Bulliard, and Kara Budor, MS: https://bit.ly/4xcFkb6
MCRA, an IQVIA business reposted this
A strong path from concept to commercialization starts with valid scientific evidence. Watch our Vice President of IVD Regulatory Affairs, James Mullally, discuss how innovators can strengthen clinical plans, support regulatory submissions, and bring promising IVD technologies to patients faster. https://bit.ly/4f4xdHd
Our global therapy Subject Matter Experts (SMEs) can help with your clinical study development and execution. If you are short on staff or time, reach out to MCRA to learn how we can help. The MCRA CRO team offers you expert insight in clinical execution to optimize your success. Learn more about our Clinical CRO offerings: https://lnkd.in/ehwSCmAm #MCRA #GlobalCRO #CRO #ClinicalResearchOrganization #medtechindustry #ClinicalTrials #ClinicalOperations #medtechinnovation #medtech #MedTech #medicaldevices #globalmedtech #medtechindustry
MCRA, an IQVIA business reposted this
Looking to strengthen your regulatory submissions? In this on-demand webinar, IQVIA MedTech and MCRA experts share how to bridge gaps between regulatory body requirements and clinical data to ensure a clear pathway to market for your product. Access the full recording here: https://bit.ly/4rC0sVE
The MCRA In-Vitro Diagnostic team offers you expert insight and direct access to regulatory and clinical leaders to optimize your success. Our expert consultants work with you to create the optimal product pathway. Learn more about MCRA’s IVD team: https://lnkd.in/dkzfE-Tf #MCRA #regulatoryaffairs #regulatory #USregulatory #FDA #FDAapproval #medicaldevice #IVD #invitrodiagnostics #IVDregulation #CRO #ClinicalResearch #ClinicalTrials #ClinicalExperts
MCRA, an IQVIA business reposted this
Two strengths, one connected path forward. With MCRA now part of IQVIA MedTech, innovators can access regulatory expertise and clinical and commercialization capabilities in one trusted place. Hear from Kelley Kennedy and Glenn Stiegman on what this means in practice. https://bit.ly/4fJr3wu
MCRA, an IQVIA business reposted this
Some decisions are easier to make when you can talk them through. At ADLM 2026, connect with IQVIA MedTech to explore options in the IVD space across clinical trials, regulatory submissions, and market access. Join us at booth 4137 in Anaheim or book a meeting that fits your schedule here: https://bit.ly/4gL8KrE
MCRA, an IQVIA business reposted this
What trends are shaping the global in vitro diagnostics market? Join IQVIA MedTech at the ADLM 2026 International Market Briefing, where David Kowalski, Principal and Global Head of IVD Consulting, will provide an update on the key developments influencing IVD markets worldwide. Learn more and register: https://lnkd.in/d-kBYZpe
See you at ADLM 2026 next week! Our clinical, regulatory, and reimbursement experts will be at the IQVIA MedTech Booth #4137, and available to discuss your IVD products. Schedule a meeting with our team, and learn more about our expertise now: https://lnkd.in/eBc9ZNT7 #ADLM2026 #IVD #invitrodiagnostics #IVDclinical #IVDregulatory #reimbursement #commercialization #MCRA